Induction of systemic immunological hyporesponsiveness by the feeding of antigen (oral tolerance) is well documented in animals'-3 and probably also occurs in man.4 Immune responses within the gut associated lymphoid tissues (GALT) have been extensively studied, and the associated cellular events examined by in vitro techniques,> ) but comparatively little is known about intestinal mucosal cell mediated immunity and its regulation in vivo.
There are as yet no methods for direct measurements of a mucosal cell mediated immune response but we") 1 and others'2 13 have shown that an increased count of intraepithelial lymphocytes, elongation of the crypts, increase in crypt cell proliferation, and a reduction in villus length, provide indirect evidence of a mucosal cell mediated immune response in experimental animals 14 and man. '5 Of these features, the intraepithelial lymphocyte count is the most sensitive index. '6 Addrcss {or corrcspondlcice: )r Stcphinil Strobel. ) Rcccved lor pLiblicdition 17 Octoher I985
In our earlier experiments on the induction of immune responses by the feeding of antigen, we found that modulation of the immune status of mice (by cyclophosphamide treatment) before antigen administration partially reversed oral tolerance '7 and induced a state of local cell mediated immunity. '4 These results led us to hypothesise that abrogation or breakdown of the normal gut immune responses such as oral tolerance may be the underlying pathogenesis of food allergic diseases, including the food protein sensitive enteropathies. In order to test this hypothesis in other states of aberrant immunity, we have examined immune responses to a fed protein antigen, ovalbumin, in animals immunomodulated by means of a graft versuts host reaction; by injection of the synthetic adjuvant N-acetyl-muramyl dipeptide (MDP); or in animals which are naturally immunologically inexperienced by virtue of their age. We here present evidence that immunomodulation prevented the induction of oral tolerance in mice, and was associated with a rise in intraepithelial lymphocyte counts on antigen re-exposure, suggesting active immunisation for mucosal cell mediated immunity. 829 shown in Figure 4 , there were no mucosal abnormalities at this time in the graft versus host reaction mice.
Positive findings were obtained in the studies of intraepithelial lymphocyte infiltration of the mucosa. All experimental groups in which prevention of oral tolerance had been achieved by immunomodulation, also had high intraepithelial lymphocyte counts after ovalbumin challenge (Figs 3, 5, and 6 ). Differences between immunomodulated and control groups (all ovalbumin fed and later challenged by a 10 day refeed) were significant at the p<O0OO1 level for MDP and immaturity groups. Mice which had been fed saline on day 12 of a graft versus host reaction still had high intraepithelial lymphocyte counts at 50 days and there was no additional increment in those which had been fed ovalbumin at the same stage of a graft versus host reaction. A considerable body of information has been accrued on factors which influence and induce oral tolerance. 1 6 10 13 17 24 25 The main objectives of the work described in this paper were to examine a range of techniques which are likely to abrogate the state of oral tolerance, and concomitantly to investigate whether mucosal delayed type hypersensitivity can be induced. By three quite different techniques, oral tolerance has been abrogated, and in two of the situations, changes suggestive of intestinal delayed type hypersensitivity were also produced after antigen challenge via the gut.
In earlier work, investigating mechanisms which regulate systemic and local immune responses after feeding, we and others have shown that pretreatment with cyclophosphamide, and oestrogen therapy, lead to partial or complete prevention of oral tolerance and at the same time induce local mucosal immune responses in the small intestinal mucosa, (as measured by a lymphocyte migration technique, and by jejunal crypt hyperplasia and raised intraepithelial lymphocyte counts after antigen refeeding). 13 17 The mechanisms of immunomodulation differ in these two systems. Cyclophosphamide acts at the T suppressor cell level whereas oestrogens activate the reticuloendothelial system and increase antigen presenting activity of macrophages. 13 6 In the experiments described in this paper we have disturbed the equilibrium between helper and suppressor cells by using MDP, a substance which acts via macrophage activation in cooperation with T helper cells.27 28 N-acetyl-muramyl dipeptide administration can lead to either immunostimulation or immunosuppression, depending on the length of time between administration of MDP and antigen exposure. The mode of action of MDP when given according to the protocol in our work, is immunostimulant, probably via macrophage activation and increased antigen presenting activity (Mowat and Strobel, unpublished). Such an interpretation is in keeping with the data of several authors who have proposed that induction of tolerance by parenteral administration of antigen reflects the function of the reticuloendothelial system.2 26 Features of jejunal histology after a 10 day antigen challenge have been used as 
